Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne Gulliver

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Journal of Cutaneous Medicine and Surgery|March 12, 2019
Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi StudyChristine Fahim, Ben Whan Kim, Marc Bourcier, et al.
The Journal of Rheumatology|July 17, 2015
Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity InitiativeCamille Roubille, Vincent Richer, Tara Starnino, et al.
Annals of the Rheumatic Diseases|March 11, 2015
Response to: 'drugs and cardiovascular risk in inflammatory arthritis: another case of glucocorticoid-bashing?' by Dr BoersCamille Roubille, Vincent Richer, Tara Starnino, et al.
Annals of the Rheumatic Diseases|January 7, 2015
The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysisCamille Roubille, Vincent Richer, Tara Starnino, et al.
The Journal of Rheumatology|May 3, 2016
Dr. Roubille, et al replyCamille Roubille, Vincent Richer, Tara Starnino, et al.
Arthritis Care & Research|November 25, 2014
Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trialsStephanie Siu, Boulos Haraoui, Robert Bissonnette, et al.
Journal of Cutaneous Medicine and Surgery|November 9, 2016
Definition of Moderate to Severe Hidradenitis Suppurativa: A Position Paper by the Canadian Hidradenitis Suppurativa Foundation (CHSF)Afsaneh Alavi, David N Adam, Ra'ed Alhusayen, et al.
American Journal of Clinical Dermatology|March 18, 2024
Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, CanadaAnastasiya Muntyanu, Raymond Milan, Mohammed Kaouache, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 3, 2022
Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativaThrasivoulos Tzellos, Kelsey R van Straalen, Athanassios Kyrgidis, et al.
Journal of Drugs in Dermatology : JDD|August 10, 2022
International Dermatology Outcome Measures (IDEOM): Report from the 2021 Annual MeetingCaterina Zagona-Prizio, Jenna Yousif, Carly Grant, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Journal of Cutaneous Medicine and Surgery|March 12, 2019
Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi StudyChristine Fahim, Ben Whan Kim, Marc Bourcier, et al.
The Journal of Rheumatology|July 17, 2015
Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity InitiativeCamille Roubille, Vincent Richer, Tara Starnino, et al.
Annals of the Rheumatic Diseases|March 11, 2015
Response to: 'drugs and cardiovascular risk in inflammatory arthritis: another case of glucocorticoid-bashing?' by Dr BoersCamille Roubille, Vincent Richer, Tara Starnino, et al.
Annals of the Rheumatic Diseases|January 7, 2015
The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysisCamille Roubille, Vincent Richer, Tara Starnino, et al.
The Journal of Rheumatology|May 3, 2016
Dr. Roubille, et al replyCamille Roubille, Vincent Richer, Tara Starnino, et al.
Arthritis Care & Research|November 25, 2014
Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trialsStephanie Siu, Boulos Haraoui, Robert Bissonnette, et al.
Journal of Cutaneous Medicine and Surgery|November 9, 2016
Definition of Moderate to Severe Hidradenitis Suppurativa: A Position Paper by the Canadian Hidradenitis Suppurativa Foundation (CHSF)Afsaneh Alavi, David N Adam, Ra'ed Alhusayen, et al.
American Journal of Clinical Dermatology|March 18, 2024
Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, CanadaAnastasiya Muntyanu, Raymond Milan, Mohammed Kaouache, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 3, 2022
Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativaThrasivoulos Tzellos, Kelsey R van Straalen, Athanassios Kyrgidis, et al.
Journal of Drugs in Dermatology : JDD|August 10, 2022
International Dermatology Outcome Measures (IDEOM): Report from the 2021 Annual MeetingCaterina Zagona-Prizio, Jenna Yousif, Carly Grant, et al.
Pageof 9